닫기
Infraware Technology
FAMILY SITE
Slide background

Biosimilar Development & Testing

Improve patient access to life-saving drugs for serious diseases with biosimilars

As the leading experts in biosimilars, we understand that demonstrating your biosimilar has fingerprint-like similarity to the reference product is a complex process. With our complete range of testing and development services from biosimilar cell line development, off-the-shelf & custom assays, through to biosafety testing and cell bank manufacturing, and our unrivalled expertise in the field we are your complete solution provider.

Biosimilar Testing Services

Work with the leading experts

The focus is on analytics during biosimilar development, with a requirement to demonstrate no clinically meaningful differences between your biosimilar candidate and the reference medicinal product.

Our expert scientists have developed a qualified suite of off-the-shelf fit for purpose assays to fully asses the binding, functional, physicochemical and structural features o your molecule, and they have extensive experience in custom assay development to reduce your time to market by offering packaged testing services to support comparability and characterization of your biosimilar.

Biosimilar Development Services

Biosimilar Cell Line Development

As a manufacturer of a biosimilar, you must develop the cell line. Our CHO (Chinese Hamster Ovary) Expression Platform is the most competitive system available for cell line development. Our expert scientists have devised a strategy to ensure critical quality attributes are taken into consideration from the very beginning of the development cycle. By doing so, we are able to choose the right clones at the clone selection stage to maximize your chances of developing a successful biosimilar. We can analyze your cell line at every stage of the CHO Expression Platform’s cycle to assess for comparability to the originator molecule.

Biosimilar Biosafety Testing

Fully cGMP Compliant Services

Fully characterizing your biosimilar is a regulatory requirement. Another is biosafety testing, as required by the FDA (Food and Drug Association) and the EMA (European Medicines Agency) to ensure your product is free of contaminants.

We pride ourselves in being a leading provider of cGMP biosafety testing for biopharmaceutical drugs and vaccines. Offering a comprehensive range of off-the-shelf biosafety assays, including, but not limited to, sterility testing, in vivo and in vitro assays, and genetic stability testing.

Copyright © 2020. Satorius. All rights reserved.
싸토리우스코리아 웹사이트는 귀하의 사용자 경험을 개선하고 귀하의 관심사에 맞는 콘텐츠를 제공하기 위해 쿠키를 사용합니다.
본인은 Sartorius가 사용자 프로필을 생성하고 관심있는 관련 있는 광고를 제공하기 위해 본인과 관련된 데이터를 처리하는 데 동의합니다.
이 동의는 자발적이며 이 웹사이트를 사용하는데 필요하지 않으며 향후 언제든지 철회할 수 있습니다.
동의
거부